We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+10.59%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$22.5B
AUM Growth
+$998M
(+4.6%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-7.19%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
3,968
New
673
Increased
1,689
Reduced
1,082
Closed
365
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$335M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$72.7M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$69.5M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$62.7M |
| 5 |
Carlyle Group
CG
|
+$58.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.17B |
| 2 |
NVIDIA
NVDA
|
+$500M |
| 3 |
Amazon
AMZN
|
+$436M |
| 4 |
Microsoft
MSFT
|
+$238M |
| 5 |
Ameren
AEE
|
+$67.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.16% |
| 2 | Consumer Discretionary | 10.95% |
| 3 | Technology | 10.04% |
| 4 | Industrials | 8.57% |
| 5 | Consumer Staples | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Gyre Therapeutics
GYRE
$648M
| $98.1K | ﹤0.01% |
+13,345
| New | +$116K |
|
3452
CVRx
CVRX
$143M
| $96.9K | ﹤0.01% |
+16,475
| New | +$114K |
|
|
XRPNW
3453
Armada Acquisition Corp II Warrant
XRPNW
$8.85M
| $94.8K | ﹤0.01% |
+351,250
| New | +$98.3K |
|
|
HDRNW
3454
Hadron Energy Warrant
HDRNW
$2.83M
| $94K | ﹤0.01% |
569,506
| – | – |
|
3455
Latham Group
SWIM
$632M
| $92.6K | ﹤0.01% |
14,518
+4,248
| +41% | +$24.7K |
|
|
TACHW
3456
Titan Acquisition Corp Warrants
TACHW
$8M
| $91.9K | ﹤0.01% |
+248,300
| New | +$71.4K |
|
|
TAVIR
3457
Tavia Acquisition Corp Right
TAVIR
| $90.9K | ﹤0.01% |
551,100
| – | – |
|
3458
Clean Energy Fuels
CLNE
$425M
| $89.8K | ﹤0.01% |
+46,055
| New | +$78.3K |
|
3459
Arq
ARQ
$88.4M
| $82.9K | ﹤0.01% |
+15,438
| New | +$67.6K |
|
3460
Sight Sciences
SGHT
$286M
| $82.6K | ﹤0.01% |
+20,009
| New | +$66.8K |
|
|
MITT
3461
TPG Mortgage Investment Trust
MITT
$225M
| $81.3K | ﹤0.01% |
+10,767
| New | +$74.5K |
|
3462
SmartRent
SMRT
$197M
| $81K | ﹤0.01% |
+81,779
| New | +$73.1K |
|
|
ACRE
3463
Ares Commercial Real Estate
ACRE
$239M
| $80.8K | ﹤0.01% |
+16,935
| New | +$75.2K |
|
3464
Cosan
CSAN
$3.12B
| $80.2K | ﹤0.01% |
15,889
-113,551
| -88% | -$613K |
|
3465
SkinHealth Systems
SKIN
$87.6M
| $78.4K | ﹤0.01% |
+41,044
| New | +$57.8K |
|
3466
Getty Images
GETY
$158M
| $78.1K | ﹤0.01% |
47,045
-39,290
| -46% | -$69.3K |
|
|
GPATW
3467
GP-Act III Acquisition Corp Warrants
GPATW
$2.3M
| $77.7K | ﹤0.01% |
250,800
-29,647
| -11% | -$7.87K |
|
3468
Granite Ridge Resources
GRNT
$615M
| $77.5K | ﹤0.01% |
12,170
-18,619
| -60% | -$103K |
|
|
HLVX
3469
DELISTED
HilleVax
HLVX
| $74.9K | ﹤0.01% |
37,625
-79,130
| -68% | -$145K |
|
3470
Neumora Therapeutics
NMRA
$306M
| $74.6K | ﹤0.01% |
101,790
-169,573
| -62% | -$128K |
|
|
VCICW
3471
DELISTED
Vine Hill Capital Investment Corp Warrant
VCICW
| $74K | ﹤0.01% |
251,969
| – | – |
|
|
TEF
3472
DELISTED
Telefonica
TEF
| $74K | ﹤0.01% |
+14,142
| New | +$71.1K |
|
3473
Riskified
RSKD
$701M
| $72.9K | ﹤0.01% |
14,600
-125,896
| -90% | -$602K |
|
|
IMMP
3474
Immutep
IMMP
$56M
| $72.2K | ﹤0.01% |
44,000
+9,000
| +26% | +$15.7K |
|
|
POLEW
3475
Andretti Acquisition Corp II Warrant
POLEW
| $71.5K | ﹤0.01% |
285,821
-15,948
| -5% | -$3.27K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q2 2025 Portfolio in Review
As of Q2 2025, Verition Fund Management held 3,968 positions worth $22.5B, up 4.6% from $21.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $1.62B in Q2 2025, closing 365 positions and reducing 1,082 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.17B position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Verition Fund Management opened a new position in Vanguard Intermediate-Term Corporate Bond ETF worth $56M.
- Verition Fund Management's largest Q2 2025 buy was Vanguard Intermediate-Term Corporate Bond ETF: 675,000 shares worth $56M.
- Verition Fund Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2025, an estimated $335M increase.
- Verition Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $500M.
- Verition Fund Management fully exited iShares Core S&P 500 ETF in Q2 2025, selling an estimated $1.17B.
- Verition Fund Management's ten largest holdings make up 11% of its $22.5B portfolio in Q2 2025.
- Verition Fund Management opened 673 new positions and closed 365 in Q2 2025.
- Verition Fund Management's portfolio value rose 4.6% quarter-over-quarter to $22.5B.
Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.